NurExone Reports Second Quarter 2022 Financial Results and Provides Business Update
Calgary, Alberta--(Newsfile Corp. - August 25, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients suffering from traumatic spinal cord injuries, released a business update and reported financial results for the quarter ended June 30, 2022."The first half of 2022 was transformative for NurExone, as we completed our go-public listing and continued to optimize...
2022-08-25 5:00 PM EDT
James Richardson, the Former CEO of EnerSpar, Updates Shareholders After the Completion of RTO with NurExone Biologic
Calgary, Alberta--(Newsfile Corp. - August 9, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spine injuries, released excerpts from a letter uploaded to Sedar today from Mr. Jay Richardson, Former CEO of EnerSpar and current director of NurExone to EnerSpar's shareholders. In the letter, Mr. Richardson thanked EnerSpar's shareholders for...
2022-08-09 9:09 AM EDT
NurExone Announces Sponsorship and Participation in Gordon Research's 2022 Extracellular Vesicles Conference in Maine, U.S.
Calgary, Alberta--(Newsfile Corp. - July 25, 2022) - NurExone Biologic Inc. (TSXV: NRX) ("NurExone" or the "Company"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other Central Nervous System ("CNS") indications, is pleased to announce that it will showcase a poster presentation at the prestigious "Understanding Extracellular Vesicle Biogenesis and Composition for Detection and Treatment of Diseases" conference,...
2022-07-25 12:27 PM EDT
NurExone Exosomes to Be Used in Cutting Edge Molecular Research at Hebrew University's Burstyn-Cohen Lab
Calgary, Alberta--(Newsfile Corp. - July 19, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other Central Nervous System ("CNS") indications, announced the signing of a Material Transfer Agreement (the "Agreement") dated July 18th, 2022 with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd....
2022-07-19 9:00 AM EDT
NurExone Provides Corporate Update
TSX Venture ExchangeBnei-Brak, Israel--(Newsfile...
2022-07-13 8:00 AM EDT
NurExone to Collaborate with Polyrizon for Intranasal Administration of Cutting-Edge Exosome-Therapy
Calgary, Alberta--(Newsfile Corp. - July 11, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announced today the signing of a collaboration agreement (the "Collaboration Agreement") with Polyrizon Ltd ("Polyrizon"), an Israeli biotech company that specializes in innovative intranasal products.Under the Collaboration...
2022-07-11 4:30 PM EDT
NurExone to Host Investor Webinar on Thursday, July 14, 2022
Bnei-Brak, Israel--(Newsfile Corp. - July 7, 2022) - NurExone Biologic Inc. (TSXV: NRX) ("NurExone" or the "Company"), a leading pharmaceutical company that develops innovative exosome-based treatments, is pleased to announce that the Company will host an investor webinar on Thursday, July 14, 2022 at 12:00 PM EST to discuss the Company's recent developments and growth outlook.Investor Webinar Overview:Date: Thursday, July 14, 2022Time: 12:00 PM ESTRegistration Link:...
2022-07-07 9:30 AM EDT
NurExone Biologic Inc. Retains Services of Thesis Capital Inc
Bnei-Brak, Israel--(Newsfile Corp. - July 6, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) ("NurExone" or the "Company") is pleased to announce that it has retained the services of Thesis Capital Inc. ("Thesis") of Toronto, Ontario, a leading capital markets advisory firm servicing Canadian small cap companies across the North American markets. Thesis will provide investor relations and advisory services to the Company, subject to TSX Venture Exchange ("TSXV")...
2022-07-06 9:16 AM EDT
NurExone Biologic Inc. to Begin Trading on TSX Venture Exchange and Retains Market Maker
Bnei-Brak, Israel--(Newsfile Corp. - June 22, 2022) - NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) ("NurExone" or the "Company") is pleased to announce that, further to its press release of June 15, 2022 announcing the closing of its reverse takeover transaction, it will commence trading on the TSX Venture Exchange (the "TSXV") under its new symbol "NRX" effective at the market opening today. NurExone also announces that it has engaged Questrade, Inc. ("Questrade") to provide...
2022-06-22 8:03 AM EDT
NurExone Biologic Inc. (Formerly, Enerspar Corp.) Announces Completion of Reverse Takeover Transaction
Calgary, Alberta--(Newsfile Corp. - June 15, 2022) - NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (the "Company") is pleased to announce that it has completed its previously announced business combination transaction (the "Transaction") with NurExone Biologic Ltd. ("NurExone"). The Transaction is a "Reverse Takeover Transaction" as such term is defined under Policy 5.2 of the TSX Venture Exchange (the "Exchange"). Subject to receiving final Exchange acceptance, the common...
2022-06-15 5:31 PM EDT
EnerSpar Announces Completion of Spin-Out
Calgary, Alberta--(Newsfile Corp. - May 31, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that further to its press releases of March 15, 2022 and May 12, 2022, the Company has completed its previously announced plan of arrangement (the "Arrangement"). Pursuant to the Arrangement the Company has completed the spin out its wholly-owned subsidiary, 1222150 B.C. Ltd ("SpinCo"), by way of a dividend-in-kind distributing the securities of the...
2022-05-31 8:30 PM EDT
EnerSpar and NurExone Announce Conditional Acceptance of Proposed Reverse Takeover Transaction
Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") and NurExone Biologic Ltd. ("NurExone") are pleased to announce that the TSX Venture Exchange ("TSXV" or the "Exchange") has conditionally accepted the previously announced reverse takeover transaction (the "RTO") of EnerSpar pursuant to a securities exchange agreement dated as amended on January 3, 2022, and amending agreement dated April 12, 2022 (collectively, the...
2022-05-17 7:25 PM EDT
EnerSpar Announces Distribution Date for Spin-Out Shares
Calgary, Alberta--(Newsfile Corp. - May 12, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that further to its press release of March 15, 2022, the Company has received court approval for its previously announced plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, the Company plans to spin out its wholly-owned subsidiary, 1222150 B.C. Ltd (the "Subsidiary"), by way of a dividend-in-kind distributing the securities of the...
2022-05-12 9:30 PM EDT
EnerSpar Announces Closing of Private Placement of Subscription Receipts
Calgary, Alberta--(Newsfile Corp. - May 5, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that further to its press release of January 18, 2022, the Company has closed a non-brokered private placement through the issuance of 4,551,814 subscription receipts (each, a "Subscription Receipt") at a price of $0.80 per Subscription Receipt for aggregate gross proceeds of $3,641,451.20 (the "Offering"). The gross proceeds of the Offering (the...
2022-05-05 7:00 PM EDT
EnerSpar and Israeli-Based Nurexone Provide Update on Progress to Closing RTO
Calgary, Alberta--(Newsfile Corp. - March 15, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce it has entered into an arrangement agreement (the "Arrangement Agreement") dated March 10, 2022, between the Company and 1222150 B.C. Ltd (the "Subsidiary"), a wholly-owned subsidiary of the Company, with respect to a plan of arrangement (the "Arrangement") pursuant to the Business Combination Act (British Columbia). Pursuant to the Arrangement the...
2022-03-15 9:04 AM EDT
EnerSpar and Israeli-Based Nurexone Announce Definitive Agreement
Calgary, Alberta--(Newsfile Corp. - January 18, 2022) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") is pleased to announce that they have entered into an arm's length securities exchange agreement dated January 3, 2022 (the "Agreement"), with Nurexone Biologic Ltd. ("Nurexone") and the shareholders of Nurexone (collectively, the "Vendors"), pursuant to which EnerSpar and Nurexone propose to complete a business combination (the "Proposed Transaction"). The Proposed...
2022-01-18 5:13 PM EST
EnerSpar and Israeli-Based Nurexone Announce RTO and New NI 43-101 Filed by EnerSpar
Calgary, Alberta--(Newsfile Corp. - August 30, 2021) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar" or the "Company") and Nurexone Biologic Ltd. ("Nurexone") are pleased to announce that they have entered an arms-length letter of intent dated 23 August 2021 (amended) pursuant to which EnerSpar and Nurexone propose to complete a business combination (the "Proposed Transaction"). The Proposed Transaction will be considered a "Reverse Takeover Transaction" for purposes of TSX Venture...
2021-08-30 7:30 AM EDT
EnerSpar Updates Extension for Filing Financial Statements and Related Documents and Updates on Previously Pending Mindfull Transaction
Calgary, Alberta--(Newsfile Corp. - July 5, 2020) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar") confirmed today that it is continuing to take advantage of the 45 day extension available for filing quarterly financial statements and related materials in ASC Blanket Order 51-517 which is expected to conclude with the required filings being done by July 14, 2020.EnerSpar also reports that it has been informed that Mindfull has filed a Notice of Intention to file a Proposal under the...
2020-07-05 5:25 PM EDT
EnerSpar Updates 45-Day Extension for Filing Annual Financial Statements and Related Documents
Calgary, Alberta--(Newsfile Corp. - June 8, 2020) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar") confirmed today that it is taking advantage of the 45-day extension available for filing annual and quarterly financial statements and related materials in ASC Blanket Order 51-517 which is expected to conclude with the required annual filings being done by June 13, 2020 and quarterly filings for Q1 2020 by July 14, 2020.EnerSpar confirms that there have been no material business...
2020-06-08 7:31 AM EDT
EnerSpar Updates 45 Day Extension for Filing Annual Financial Statements and Related Documents and Longer Extension for AGM Materials
Calgary, Alberta--(Newsfile Corp. - May 8, 2020) - EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) ("EnerSpar") announced today that its taking advantage of the 45 day extension available for filing annual financial statements and related materials in ASC Blanket Order 51-517 is expected to conclude with the required filings being done by May 13, 2020.EnerSpar confirms that there have been no material business developments not previously disclosed.About EnerSpar:EnerSpar is a TSX Venture Exchange Tier...
2020-05-08 9:34 AM EDT